The subject of the order is the supply of cytostatic drug anagrelide hydrochloride meeting the requirements specified in the catalogs of reimbursement drugs used in chemotherapy defined in Regulation No. 58/2018 / DGL of the President of the National Health Fund of 25.6.2018 on defining the conditions for the conclusion and implementation of contracts such as hospital treatment in in the field of chemotherapy (with later changes). - in the assortment and quantities specified in detail in Annex 4 to the ToR

The order includes the cytostatic drug anagrelide hydrochloride, which is described in detail in Annex 4 to the ToR - an assortment and price form.